Drug Manufacturing

Sep 28, 2018
By Pharmaceutical Technology Editors
Romaco Siebler and Huhtamaki will premiere a push-through strip packaging for pharmaceuticals at CPhI WorldWide 2018.
Sep 27, 2018
By Pharmaceutical Technology Editors
The World Packaging Organization will present a keynote session at CPhI discussing trends affecting pharmaceutical packaging, including user-friendly design.
Sep 27, 2018
By Pharmaceutical Technology Editors
The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.
Sep 27, 2018
By Pharmaceutical Technology Editors
GE Healthcare, Cobra Biologics, and the Centre for Process Innovation (CPI) have entered into a collaboration to advance manufacturing of adeno-associated virus vectors for gene therapy.
Sep 26, 2018
By Pharmaceutical Technology Editors
Nanjing-based PharmaBlock Sciences acquired a GMP-compliant manufacturing facility in Shangyu, China from Porton Pharma Solutions.
Sep 25, 2018
By Pharmaceutical Technology Editors
Cell-line quality has a significant impact on biologic drug quality; learn more about this and other upstream challenges at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Sep 24, 2018
By Pharmaceutical Technology Editors
A keynote session at CPhI will discuss how the trend to personalized medicine affects pharmaceutical packaging.
Sep 24, 2018
By Pharmaceutical Technology Editors
FDA awarded nearly $3 million in grants for continuous manufacturing and other advanced manufacturing technologies as part of the agency’s efforts to ensure a robust and reliable supply of biological products.
Sep 20, 2018
By Pharmaceutical Technology Editors
The biopharmaceutical company will invest approximately $800 million to expand facilities and manufacturing capacity at its campus in Rensselaer County, NY.
Sep 20, 2018
By Pharmaceutical Technology Editors
BeiGene is set to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies.
native1_300x100
lorem ipsum